SPECTRAL MEDICAL (Germany) Performance
| SD4 Stock | EUR 0.37 0.01 2.78% |
The entity has a beta of 0.29, which indicates not very significant fluctuations relative to the market. As returns on the market increase, SPECTRAL MEDICAL's returns are expected to increase less than the market. However, during the bear market, the loss of holding SPECTRAL MEDICAL is expected to be smaller as well. At this point, SPECTRAL MEDICAL has a negative expected return of -0.0141%. Please make sure to validate SPECTRAL MEDICAL's downside deviation, information ratio, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if SPECTRAL MEDICAL performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days SPECTRAL MEDICAL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, SPECTRAL MEDICAL is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
SPECTRAL |
SPECTRAL MEDICAL Relative Risk vs. Return Landscape
If you would invest 39.00 in SPECTRAL MEDICAL on October 11, 2024 and sell it today you would lose (3.00) from holding SPECTRAL MEDICAL or give up 7.69% of portfolio value over 90 days. SPECTRAL MEDICAL is currently producing negative expected returns and takes up 4.9928% volatility of returns over 90 trading days. Put another way, 44% of traded stocks are less volatile than SPECTRAL, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
SPECTRAL MEDICAL Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SPECTRAL MEDICAL's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SPECTRAL MEDICAL, and traders can use it to determine the average amount a SPECTRAL MEDICAL's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0028
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SD4 |
Estimated Market Risk
| 4.99 actual daily | 44 56% of assets are more volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average SPECTRAL MEDICAL is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SPECTRAL MEDICAL by adding SPECTRAL MEDICAL to a well-diversified portfolio.
SPECTRAL MEDICAL Fundamentals Growth
SPECTRAL Stock prices reflect investors' perceptions of the future prospects and financial health of SPECTRAL MEDICAL, and SPECTRAL MEDICAL fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SPECTRAL Stock performance.
| Return On Equity | -7.84 | |||
| Return On Asset | -0.74 | |||
| Operating Margin | (6.38) % | |||
| Shares Outstanding | 278.22 M | |||
| Revenue | 1.66 M | |||
| EBITDA | (10.4 M) | |||
| Cash And Equivalents | 3.43 M | |||
| Cash Per Share | 0.01 X | |||
| Debt To Equity | 14.70 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (2.19 M) | |||
| Earnings Per Share | (0.03) X | |||
About SPECTRAL MEDICAL Performance
By analyzing SPECTRAL MEDICAL's fundamental ratios, stakeholders can gain valuable insights into SPECTRAL MEDICAL's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SPECTRAL MEDICAL has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SPECTRAL MEDICAL has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada. SPECTRAL MEDICAL operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 18 people.Things to note about SPECTRAL MEDICAL performance evaluation
Checking the ongoing alerts about SPECTRAL MEDICAL for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SPECTRAL MEDICAL help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SPECTRAL MEDICAL generated a negative expected return over the last 90 days | |
| SPECTRAL MEDICAL has some characteristics of a very speculative penny stock | |
| SPECTRAL MEDICAL has high historical volatility and very poor performance | |
| SPECTRAL MEDICAL has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1.66 M. Net Loss for the year was (2.91 M) with profit before overhead, payroll, taxes, and interest of 1.22 M. | |
| SPECTRAL MEDICAL has accumulated about 3.43 M in cash with (2.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing SPECTRAL MEDICAL's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SPECTRAL MEDICAL's stock is overvalued or undervalued compared to its peers.
- Examining SPECTRAL MEDICAL's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SPECTRAL MEDICAL's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SPECTRAL MEDICAL's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SPECTRAL MEDICAL's stock. These opinions can provide insight into SPECTRAL MEDICAL's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for SPECTRAL Stock analysis
When running SPECTRAL MEDICAL's price analysis, check to measure SPECTRAL MEDICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SPECTRAL MEDICAL is operating at the current time. Most of SPECTRAL MEDICAL's value examination focuses on studying past and present price action to predict the probability of SPECTRAL MEDICAL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SPECTRAL MEDICAL's price. Additionally, you may evaluate how the addition of SPECTRAL MEDICAL to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |